Free Trial
NASDAQ:PDEX

Pro-Dex (PDEX) Stock Price, News & Analysis

Pro-Dex logo
$46.45 +0.95 (+2.09%)
Closing price 04:00 PM Eastern
Extended Trading
$46.68 +0.23 (+0.51%)
As of 05:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Pro-Dex Stock (NASDAQ:PDEX)

Key Stats

Today's Range
$45.78
$47.46
50-Day Range
$38.41
$53.50
52-Week Range
$21.20
$70.26
Volume
19,140 shs
Average Volume
40,113 shs
Market Capitalization
$151.43 million
P/E Ratio
16.59
Dividend Yield
N/A
Price Target
$56.00
Consensus Rating
Buy

Company Overview

Pro-Dex Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
41st Percentile Overall Score

PDEX MarketRank™: 

Pro-Dex scored higher than 41% of companies evaluated by MarketBeat, and ranked 635th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Pro-Dex has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Pro-Dex has received no research coverage in the past 90 days.

  • Read more about Pro-Dex's stock forecast and price target.
  • Earnings Growth

    Earnings for Pro-Dex are expected to grow by 3.00% in the coming year, from $2.00 to $2.06 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pro-Dex is 16.59, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.67.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pro-Dex is 16.59, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 31.26.

  • Price to Book Value per Share Ratio

    Pro-Dex has a P/B Ratio of 5.14. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Pro-Dex's valuation and earnings.
  • Percentage of Shares Shorted

    12.76% of the float of Pro-Dex has been sold short.
  • Short Interest Ratio / Days to Cover

    Pro-Dex has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in Pro-Dex has recently increased by 11.87%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Pro-Dex does not currently pay a dividend.

  • Dividend Growth

    Pro-Dex does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.76% of the float of Pro-Dex has been sold short.
  • Short Interest Ratio / Days to Cover

    Pro-Dex has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in Pro-Dex has recently increased by 11.87%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Pro-Dex has a news sentiment score of 0.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Pro-Dex this week, compared to 1 article on an average week.
  • Search Interest

    3 people have searched for PDEX on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added Pro-Dex to their MarketBeat watchlist in the last 30 days. This is a decrease of -57% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Pro-Dex insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    47.50% of the stock of Pro-Dex is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 15.28% of the stock of Pro-Dex is held by institutions.

  • Read more about Pro-Dex's insider trading history.
Receive PDEX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PDEX Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.tc pixel
Pro-Dex, Inc. (PDEX) - Yahoo Finance
See More Headlines

PDEX Stock Analysis - Frequently Asked Questions

Pro-Dex's stock was trading at $46.75 at the start of the year. Since then, PDEX shares have decreased by 0.6% and is now trading at $46.45.

Pro-Dex, Inc. (NASDAQ:PDEX) posted its quarterly earnings data on Thursday, May, 1st. The medical instruments supplier reported $0.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.51. The medical instruments supplier earned $17.41 million during the quarter, compared to analyst estimates of $17.70 million. Pro-Dex had a net margin of 14.61% and a trailing twelve-month return on equity of 29.08%.

Pro-Dex's top institutional shareholders include Geode Capital Management LLC (1.58%), JPMorgan Chase & Co. (1.10%), Ritholtz Wealth Management (0.65%) and D.A. Davidson & CO. (0.32%). Insiders that own company stock include Alisha Charlton and Angelita Rebamontan Domingo.
View institutional ownership trends
.

Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pro-Dex investors own include NVIDIA (NVDA), Broadcom (AVGO), Novo Nordisk A/S (NVO), Adobe (ADBE), ServiceNow (NOW), Arista Networks (ANET) and Jabil (JBL).

Company Calendar

Last Earnings
5/01/2025
Today
8/28/2025
Next Earnings (Estimated)
9/04/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PDEX
CIK
788920
Employees
140
Year Founded
1975

Price Target and Rating

High Price Target
$56.00
Low Price Target
$56.00
Potential Upside/Downside
+19.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
$2.80
Trailing P/E Ratio
16.74
Forward P/E Ratio
23.44
P/E Growth
N/A
Net Income
$2.13 million
Net Margins
14.61%
Pretax Margin
19.32%
Return on Equity
29.08%
Return on Assets
16.19%

Debt

Debt-to-Equity Ratio
0.28
Current Ratio
2.73
Quick Ratio
1.45

Sales & Book Value

Annual Sales
$64.12 million
Price / Sales
2.38
Cash Flow
$0.96 per share
Price / Cash Flow
48.78
Book Value
$9.03 per share
Price / Book
5.19

Miscellaneous

Outstanding Shares
3,261,000
Free Float
1,712,000
Market Cap
$152.89 million
Optionable
Not Optionable
Beta
0.19

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:PDEX) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners